The neuroacanthocytosis syndromes, VPS13A and XK diseases, are characterized by neurological, cognitive, and psychiatric symptoms attributable to progressive degeneration of the basal ganglia, in addition to other features including seizures, peripheral neuropathy and myopathy. Here, VPS13A is linked to neuroacanthocytosis.